China NMPA Drug Inspection - Qingyang Shenzhou Tongtai Pharmaceutical Co., Ltd. - Chrysanthemum (Hangzhou chrysanthemum)
China NMPA drug inspection for Qingyang Shenzhou Tongtai Pharmaceutical Co., Ltd. published September 22, 2021. Drug: Chrysanthemum (Hangzhou chrysanthemum). On September 22, 2021, the Hubei Provincial Drug Administration published its second drug quality bulletin of the year,
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Qingyang Shenzhou Tongtai Pharmaceutical Co., Ltd. published September 22, 2021. Drug: Chrysanthemum (Hangzhou chrysanthemum). On September 22, 2021, the Hubei Provincial Drug Administration published its second drug quality bulletin of the year,
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox